Vitamin markets remain weak, with prices either declining or stable across most regions. Supply generally exceeds demand, and buyers are cautious, securing only part of their Q3 needs. Below is a brief update on key vitamins, including E 50%, A 1000, D3 500, D-Calpan, and B3. Highlights: Vitamin E 50%: Prices continue to decline across all regions. No updates on BASF’s vitamin E production restart. Buyers are cautious and only partially contracted for Q3.
Vitamin A 1000: BASF has lifted
Get full access to all stories on All About Feed
This Premium article is exclusively available for subscribers.
Obtain insights from exclusive interviews
Dive into articles covering trending industry topics
Stay up-to-date on the market trends
All the news is brought to you by experienced editors and experts from around the world